Katalog
Hilfe
Bauen Sie hier Ihr Portfolio auf
Geben Sie die Menge neben den benötigten Aktien ein – Ihr Portfolio wird automatisch erstellt.
Schneller Screener: nach Kategorie und Empfehlung filtern, Fundamentaldaten, Kennzahlen und Unternehmensprofile überprüfen.
| Unternehmen | Kategorie | Preis | Δ% | Div% | Vol20 | EPS(TTM) | QoQ | EPS(SPR) | Stil | Horizont | Pot. | Risiko | Empfehlung | Portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abivax (ABVX) | Biotechnologie | 125.70 | 0.00% | 0.0% | 8.8% | -5.84 | -200.0% | 24.8% | Wachstum | Mittel | 39 | 76 | Verkaufen |
|
| Alnylam Pharmaceuticals (ALNY) | Biotechnologie | 271.77 | 0.00% | 0.0% | 2.3% | 4.36 | 6.4% | 73.2% | Wachstum | Mittel | 57 | 70 | Halten |
|
| Apogee Therapeutics (APGE) | Biotechnologie | 134.28 | 0.00% | 0.0% | 0.1% | -4.33 | 0.0% | 0.0% | Wachstum | Lang | 46 | 70 | Verkaufen |
|
| Arrowhead Pharmaceuticals (ARWR) | Biotechnologie | 85.60 | 0.00% | 0.0% | 3.1% | -2.14 | -72.1% | 21.2% | Wachstum | Mittel | 72 | 65 | Kaufen |
|
| Bio-Techne (TECH) | Biotechnologie | 71.60 | 0.00% | 0.4% | 0.3% | 0.71 | 5.3% | -3.6% | Wachstum | Mittel | 54 | 45 | Halten |
|
| Biohaven (BHVN) | Biotechnologie | 14.32 | 0.00% | 0.0% | 3.8% | -5.67 | 0.0% | -2.3% | Wachstum | Mittel | 42 | 74 | Verkaufen |
|
| BioNTech (BNTX) | Biotechnologie | 89.33 | 0.00% | 0.0% | 1.5% | -5.09 | -86.6% | 3.7% | Wachstum | Mittel | 24 | 85 | Verkaufen |
|
| Celcuity (CELC) | Biotechnologie | 82.62 | 0.00% | 0.0% | 5.2% | -3.89 | 0.0% | 6.7% | Wachstum | Mittel | 25 | 84 | Verkaufen |
|
| Centessa Pharmaceuticals (CNTA) | Pharma | 40.50 | 0.00% | 93.8% | 0.0% | -1.78 | 0.0% | -36.8% | Wachstum | Mittel | 30 | 70 | Verkaufen |
|
| Cidara Therapeutics (CDTX) | Biotechnologie | 221.38 | 0.00% | 0.0% | 0.0% | -11.78 | 0.0% | 0.0% | Wachstum | Mittel | 30 | 80 | Verkaufen |
|
| Corcept Therapeutics (CORT) | Biotechnologie | 95.36 | 0.00% | 0.0% | 2.4% | 0.45 | -18.4% | -111.3% | Wachstum | Mittel | 57 | 70 | Halten |
|
| Corvus Pharmaceuticals (CRVS) | Biotechnologie | 13.07 | 0.00% | 0.0% | 3.0% | -0.55 | 0.0% | -7.1% | Wachstum | Mittel | 20 | 80 | Verkaufen |
|
| CPRX (CPRX) | Gesundheitswesen | 31.49 | 0.00% | 0.0% | 0.0% | 1.80 | -2.1% | 15.6% | Wachstum | Mittel | 62 | 40 | Kaufen |
|
| Crinetics Pharmaceuticals (CRNX) | Biotechnologie | 83.73 | 0.00% | 0.0% | 21.4% | -5.14 | 74.2% | 0.0% | Wachstum | Mittel | 70 | 60 | Halten |
|
| Definium Therapeutics (DFTX) | Biotechnologie | 43.17 | 0.00% | 0.0% | 3.6% | -2.50 | 0.0% | -44.3% | Wachstum | Mittel | 41 | 67 | Verkaufen |
|
| Disc Medicine (IRON) | Biotechnologie | 74.12 | 0.00% | 0.0% | 2.0% | -6.64 | 0.0% | -1.7% | Wachstum | Mittel | 31 | 70 | Verkaufen |
|
| ImmunityBio (IBIO) | Biotechnologie | 1.43 | 0.00% | 0.0% | 2.3% | -0.58 | -100.0% | -16.7% | Wachstum | Mittel | 20 | 80 | Verkaufen |
|
| Immunovant (IMVT) | Biotechnologie | 39.41 | 0.00% | 0.0% | 1.8% | -2.78 | 0.0% | -23.3% | Wachstum | Mittel | 40 | 70 | Verkaufen |
|
| Incyte (INCY) | Pharma | 117.67 | 0.00% | 0.0% | 1.2% | 7.30 | -15.5% | 31.2% | Wachstum | Mittel | 69 | 41 | Kaufen |
|
| Intellia Therapeutics (NTLA) | Biotechnologie | 10.73 | 0.00% | 0.0% | 3.8% | -3.54 | -34.6% | 12.0% | Wachstum | Mittel | 25 | 80 | Verkaufen |
|
| Kymera Therapeutics (KYMR) | Biotechnologie | 110.57 | 0.00% | 0.0% | 2.7% | -3.58 | 1101.6% | 0.0% | Wachstum | Lang | 68 | 69 | Halten |
|
| Ligand Pharmaceuticals (LGND) | Pharma | 300.53 | 0.00% | 0.0% | 1.8% | 7.84 | -13.3% | -11.4% | Wachstum | Mittel | 45 | 70 | Verkaufen |
|
| MGX (MGX) | Gesundheitswesen | 1.21 | 0.00% | 0.0% | 2.3% | -2.30 | -68.1% | 0.0% | Wert | Lang | 20 | 85 | Verkaufen |
|
| Moderna (MRNA) | Pharma | 54.07 | 0.00% | 0.0% | 4.4% | -8.15 | -42.6% | 60.9% | Wachstum | Mittel | 39 | 76 | Verkaufen |
|
| Ovid Therapeutics (OVID) | Biotechnologie | 2.33 | 0.00% | 0.0% | 3.1% | -0.35 | -100.0% | 0.0% | Wachstum | Mittel | 30 | 80 | Verkaufen |
|
| Regeneron Pharmaceuticals (REGN) | Biotechnologie | 656.01 | 0.00% | 0.5% | 1.8% | 42.53 | -7.2% | 6.3% | Wachstum | Lang | 55 | 66 | Halten |
|
| Regenxbio (RGNX) | Biotechnologie | 9.73 | 0.00% | 0.0% | 5.4% | -5.60 | -78.9% | -26.5% | Wachstum | Kurz | 25 | 80 | Verkaufen |
|
| Revolution Medicines (RVMD) | Pharma | 189.23 | 0.00% | 0.0% | 1.7% | -7.11 | 0.0% | -25.1% | Wachstum | Mittel | 42 | 70 | Verkaufen |
|
| Sarepta Therapeutics (SRPT) | Biotechnologie | 15.68 | 0.00% | 0.0% | 2.8% | 0.62 | 65.0% | 223.8% | Wachstum | Mittel | 33 | 75 | Verkaufen |
|
| Scholar Rock (SRRK) | Biotechnologie | 47.67 | 0.00% | 0.0% | 2.6% | -3.45 | 0.0% | -1.2% | Wachstum | Mittel | 30 | 72 | Verkaufen |
|